Pricing

Biodexa Pharmaceuticals Plc (BDRX)

followers ·
Sector:
HEALTH CARE
Industry:
PHARMACEUTICALS
SIC:
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
CEO:
Stephen A. Stamp
Employees:
20
1 CASPIAN POINT, CASPIAN WAY, CARDIFF, X0, CF10 4DQ
44 (0)1235 888300
    Formally known as:
  • Dara Biosciences
  • Point Therapeutics Inc
Stock Split History
DateRatio
2019-04-08 1:10
2020-03-03 1:5
2022-09-26 1:5
2023-03-27 1:4
2023-07-05 1:80
Midatech Pharma plc focuses on the research and development of medicines in the United Kingdom, rest of Europe, and internationally. The company is developing MTX110, a direct delivery treatment for diffuse intrinsic pontine glioma, medulloblastomas, and glioblastoma multiforme. MTX114, an immuno-suppressant for topical application in psoriasis, MTD211, a long-acting formulation of brexpiprazole for the treatment of schizophrenia and adjunctive treatment of major depressive disorder.
All 13F Filers Prior Change Hedge Funds 1 Prior Change
InvestorHistoryShares Held or Principal AmtMarket Value% of PortfolioPrevious % of PortfolioRankChange in Shares% OwnershipQtr 1st OwnedEst. Avg PriceSourceSource DateDate Reported
No data available